Heren Health Co.,Ltd. (SHE:300550)
China · Delayed Price · Currency is CNY 13.95
+0.10 (0.72%)
At close: Oct 9, 2026
Heren Health Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,663 | 3,810 | 3,978 | 3,936 | 4,154 | 3,405 | |
Market Cap Growth | 13.41% | -4.22% | 1.07% | -5.25% | 21.99% | 0.16% |
Enterprise Value | 3,246 | 3,425 | 3,632 | 3,602 | 3,784 | 2,896 |
Last Close Price | 13.95 | 14.48 | 15.09 | 14.88 | 15.70 | 12.73 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 157.05 | 79.93 | 101.22 | 100.62 | - | 98.75 |
Forward PE | - | 48.83 | 48.83 | 48.83 | 48.83 | 48.83 |
PS Ratio | 8.44 | 8.76 | 9.80 | 8.96 | 11.53 | 7.34 |
PB Ratio | 3.21 | 3.23 | 3.55 | 3.64 | 3.99 | 2.93 |
P/TBV Ratio | 3.57 | 3.54 | 3.72 | 3.89 | 4.16 | 3.19 |
P/FCF Ratio | 46.43 | 45.40 | - | 67.27 | - | - |
P/OCF Ratio | 30.41 | 30.26 | 497.41 | 47.21 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 7.48 | 7.87 | 8.95 | 8.20 | 10.50 | 6.24 |
EV/EBITDA Ratio | 125.19 | 59.18 | 56.78 | 63.18 | - | 70.26 |
EV/EBIT Ratio | 158.49 | 73.55 | 122.78 | 137.78 | - | 124.00 |
EV/FCF Ratio | 41.15 | 40.82 | - | 61.56 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0.04 | 0.09 | 0.12 | 0.12 | 0.06 |
Debt / EBITDA Ratio | 0.08 | 0.89 | 1.48 | 2.19 | - | 1.71 |
Debt / FCF Ratio | 0.03 | 0.62 | - | 2.20 | - | - |
Net Debt / Equity Ratio | -0.39 | -0.46 | -0.42 | -0.47 | -0.43 | -0.49 |
Net Debt / EBITDA Ratio | -18.04 | -9.35 | -7.28 | -8.89 | 6.59 | -13.78 |
Net Debt / FCF Ratio | -5.66 | -6.45 | 12.28 | -8.67 | 3.59 | 6.02 |
Asset Turnover | 0.30 | 0.29 | 0.28 | 0.31 | 0.25 | 0.30 |
Inventory Turnover | 7.24 | 11.88 | 11.89 | 7.31 | 5.16 | 5.61 |
Quick Ratio | 3.94 | 3.69 | 3.46 | 3.25 | 2.84 | 3.32 |
Current Ratio | 4.14 | 3.77 | 3.52 | 3.33 | 3.01 | 3.52 |
Return on Equity (ROE) | 2.09% | 4.18% | 3.39% | 3.67% | -7.65% | 3.00% |
Return on Assets (ROA) | 0.90% | 1.97% | 1.27% | 1.14% | -4.14% | 0.95% |
Return on Invested Capital (ROIC) | 2.90% | 6.91% | 4.81% | 4.28% | -16.52% | 4.43% |
Return on Capital Employed (ROCE) | 1.80% | 3.90% | 2.60% | 2.40% | -9.30% | 2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.53% | 1.25% | 0.99% | 0.99% | -2.01% | 1.01% |
FCF Yield | 2.15% | 2.20% | -0.95% | 1.49% | -3.04% | -2.77% |
Dividend Yield | 0.22% | 0.21% | 0.17% | 0.20% | - | 0.16% |
Payout Ratio | 46.13% | 18.61% | 30.88% | 11.28% | - | 25.71% |
Buyback Yield / Dilution | 25.18% | -1.08% | -0.46% | -0.17% | 1.85% | -10.66% |
Total Shareholder Return | 25.39% | -0.87% | -0.30% | 0.03% | 1.85% | -10.51% |